Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|May 2, 2025
B4GALT5 inhibits CD8<sup>+</sup> T-cell response by downregulating MHC-I level through ERAD pathway in PDACXin Xing, Shi-Qi Yin, Xia-Qing Li, et al.
American Journal of Cancer Research|March 26, 2019
SFRP4 is a prognostic marker and correlated with Treg cell infiltration in pancreatic ductal adenocarcinomaMin-Wei Yang, Ling-Ye Tao, Jian-Yu Yang, et al.
Molecular Oncology|May 1, 2021
SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axisJian-Yu Yang, Yan-Miao Huo, Min-Wei Yang, et al.
Cancer Letters|March 26, 2021
CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinomaJun-Feng Zhang, Ling-Ye Tao, Min-Wei Yang, et al.
Cell Cycle (Georgetown, Tex.)|July 28, 2017
The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinomaDe-Jun Liu, Yue-Xia Xie, Xiao-Xing Liu, et al.
Theranostics|February 24, 2025
OASL promotes immune evasion in pancreatic ductal adenocarcinoma by enhancing autolysosome-mediated degradation of MHC-IXin Xing, Xia-Qing Li, Shi-Qi Yin, et al.
Journal of Cancer|November 22, 2017
High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell ProliferationChao-Qin Shen, Ting-Ting Yan, Wei Liu, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 20, 2023
Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancerHong-Fei Yao, Da-Peng Xu, Jia-Hao Zheng, et al.
Cancer Cell International|July 25, 2024
The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathwayYu-Heng Zhu, Qin-Yuan Jia, Hong-Fei Yao, et al.
World Journal of Gastroenterology|April 24, 2019
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomasMin-Wei Yang, Xue-Liang Fu, Yong-Sheng Jiang, et al.
Pageof 6